rs536522394

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_000250.2(MPO):​c.1555_1568delATGGAACCCAACCC​(p.Met519ProfsTer21) variant causes a frameshift change. The variant allele was found at a frequency of 0.00111 in 1,614,232 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00081 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 1 hom. )

Consequence

MPO
NM_000250.2 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 6.96
Variant links:
Genes affected
MPO (HGNC:7218): (myeloperoxidase) Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil azurophilic granules. Produced as a single chain precursor, myeloperoxidase is subsequently cleaved into a light and heavy chain. The mature myeloperoxidase is a tetramer composed of 2 light chains and 2 heavy chains. This enzyme produces hypohalous acids central to the microbicidal activity of neutrophils. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 17-58273466-GGGGTTGGGTTCCAT-G is Pathogenic according to our data. Variant chr17-58273466-GGGGTTGGGTTCCAT-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3629.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-58273466-GGGGTTGGGTTCCAT-G is described in Lovd as [Pathogenic]. Variant chr17-58273466-GGGGTTGGGTTCCAT-G is described in Lovd as [Likely_pathogenic]. Variant chr17-58273466-GGGGTTGGGTTCCAT-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MPONM_000250.2 linkc.1555_1568delATGGAACCCAACCC p.Met519ProfsTer21 frameshift_variant Exon 9 of 12 ENST00000225275.4 NP_000241.1 P05164-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MPOENST00000225275.4 linkc.1555_1568delATGGAACCCAACCC p.Met519ProfsTer21 frameshift_variant Exon 9 of 12 1 NM_000250.2 ENSP00000225275.3 P05164-1

Frequencies

GnomAD3 genomes
AF:
0.000808
AC:
123
AN:
152220
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00153
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000791
AC:
199
AN:
251474
AF XY:
0.000765
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00149
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.00114
AC:
1662
AN:
1461894
Hom.:
1
AF XY:
0.00111
AC XY:
808
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
AC:
9
AN:
33480
Gnomad4 AMR exome
AF:
0.000313
AC:
14
AN:
44724
Gnomad4 ASJ exome
AF:
0.00153
AC:
40
AN:
26136
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
86258
Gnomad4 FIN exome
AF:
0.0000562
AC:
3
AN:
53420
Gnomad4 NFE exome
AF:
0.00140
AC:
1552
AN:
1112012
Gnomad4 Remaining exome
AF:
0.000662
AC:
40
AN:
60396
Heterozygous variant carriers
0
106
212
318
424
530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000807
AC:
123
AN:
152338
Hom.:
0
Cov.:
32
AF XY:
0.000805
AC XY:
60
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.000120
AC:
0.000120279
AN:
0.000120279
Gnomad4 AMR
AF:
0.000523
AC:
0.000522739
AN:
0.000522739
Gnomad4 ASJ
AF:
0.00144
AC:
0.00144009
AN:
0.00144009
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.00153
AC:
0.0015286
AN:
0.0015286
Gnomad4 OTH
AF:
0.000473
AC:
0.000473485
AN:
0.000473485
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000344
Hom.:
0
Bravo
AF:
0.000778
EpiCase
AF:
0.00180
EpiControl
AF:
0.00190

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Myeloperoxidase deficiency Pathogenic:4
May 01, 2004
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 08, 2024
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 11, 2023
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Pathogenic:3
Mar 17, 2022
AiLife Diagnostics, AiLife Diagnostics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in the compound heterozygous state in a patient with MPO deficiency in published literature (PMID: 9354683); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Published functional studies demonstrate a damaging effect as neutrophils completely deficient in MPO fail to form neutrophil extracellular traps (NETs) (PMID: 20974672); This variant is associated with the following publications: (PMID: 12773517, 32758448, 34426522, 31589614, 33727708, 31980526, 37954595, 32758447, 33531667, 35761024, 20974672, 9354683) -

Jan 31, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MPO-related disorder Pathogenic:1
Sep 19, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The MPO c.1555_1568del14 variant is predicted to result in a frameshift and premature protein termination (p.Met519Profs*21). This variant was reported as pathogenic for myeloperoxidase deficiency (Romano et al. 1997. PubMed ID: 9354683; Hou et al. 2020. PubMed ID: 31980526; Vergano et al. 2020. PubMed ID: 32758448). This variant is reported in 0.15% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in MPO are expected to be pathogenic. This variant is interpreted as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs536522394; hg19: chr17-56350827; API